First reports have shown that serum VCAM-1 and ICAM-1 levels were increased in COVID-19 patients (n = 36), as compared to healthy subjects (n = 16), positively correlating with disease severity and tending to decrease during convalescence [175]. The gene discussed is ICAM1; the disease is COVID-19.